Company news
Thx Pharma (EURONEXT:ALTHX) news
Every Thx Pharma press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Thx Pharma : Corrected press release : THX Pharma and the Beyond Batten Disease Foundation Announce the Grant of a European Patent Protec...
September 9, 2026
Thx Pharma : THX Pharma and the Beyond Batten Disease Foundation Announce the Grant of a European Patent Protecting the Use of Batten-1 i...
September 8, 2026
Thx Pharma : THX Pharma, BBDF and Biocodex Announce Regulatory Submissions for the Phase 3 Clinical Trial of Batten-1 in Juvenile Batten ...
September 1, 2026
Thx Pharma : THX Pharma Reports Cash Position as of June 30, 2026
July 9, 2026
Thx Pharma : THX Pharma Announces the Appointment of Sophie Jacq Lapointe to its Board of Directors
June 23, 2026
Thx Pharma : Allinvest Securities Initiates Analyst Coverage on THX Pharma with Buy Recommendation
June 16, 2026
Thx Pharma : THX Pharma (Theranexus) and Exeltis secure EMA approval of the paediatric investigation plan (PIP) for TX01, unlocking the P...
June 9, 2026
THX Pharma : Publishes Its 2025 Annual Results, Cash Position as of March 31, 2026, and Provides a Business Update
April 28, 2026
Thx Pharma : THX Pharma Publishes Its 2025 Annual Results, Cash Position as of March 31, 2026, and Provides a Business Update
April 28, 2026
THX Pharma : announces the publication of its letter to shareholders
March 25, 2026
THX Pharma : Reports Its Cash Position as of December 31, 2025
February 19, 2026
THX Pharma : to Host a Webinar to Discuss Its Strategic Agreement with Biocodex
February 12, 2026
THX Pharma and Biocodex Announce a Strategic Licensing Agreement in Batten, Gaucher and Niemann-Pick Type C Diseases
February 10, 2026
Thx Pharma : THX Pharma Announces its 2026 Financial Calendar
January 20, 2026
THX Pharma : Shareholders' Letter
January 8, 2026
Thx Pharma : THX Pharma announces the publication of its letter to shareholders
January 8, 2026
Thx Pharma : THX Pharma Announces the Appointment of Julien Veys as Deputy Chief Executive Officer
January 7, 2026
THX Pharma : announces the strong success of its approximately EUR 8 million capital increase to support its continued development and st...
November 13, 2025
Thx Pharma : THX Pharma announces the strong success of its approximately EUR 8 million capital increase to support its continued develop...
November 13, 2025
THX Pharma : announces the launch of a capital increase with preferential subscription rights of nearly EUR 8 million
October 23, 2025
Thx Pharma : THX Pharma announces the launch of a capital increase with preferential subscription rights of nearly EUR 8 million
October 23, 2025
Theranexus Becomes THX Pharma: A Strategic Evolution Toward the Commercialization of Its Medicines for Rare Diseases
September 29, 2025